Peptide Initiative

Condition Spotlight

Chronic Skin Wounds That Won't Heal

A wound that won't close. A diabetic foot ulcer that keeps getting infected. A venous leg ulcer that's been there for years. The psychological and physical toll is real - and so is the risk of amputation, scarring, and permanent loss of function.

Becaplermin (Regranex)Thymosin Beta-4BPC-157EGF (Topical)GHK-CuLL-37 (Cathelicidin)
6Peptides in this guide
Week 1-2 → 6+ MonthsTimeline
1Lifestyle area
4Reality checks

  • Persistent Open Wounds

    Ulcers that don't progress toward healing despite standard care

  • Chronic Inflammation

    The wound stays inflamed, preventing progression to the healing phase

  • Infection Risk

    Diabetic ulcers especially vulnerable to bacterial colonization and sepsis

Understanding Wound Healing

Why Some Wounds Get Stuck

Normally, wound healing follows a predictable sequence. Your body signals growth factors like PDGF and EGF, which recruit fibroblasts to lay down new collagen, stimulate angiogenesis (blood vessel formation), and orchestrate epithelialization (new skin growth). But in chronic wounds—especially diabetic and venous ulcers—this process stalls. High blood glucose damages the nerves that sense injury and the blood vessels that deliver oxygen and nutrients. Venous insufficiency creates a hostile microenvironment with poor drainage and oxygen deprivation. The growth factors get produced, but at insufficient levels or in the wrong timing. Inflammatory cells persist when they should be clearing out. The wound stays stuck in the inflammatory phase. The result? A ulcer that's open for months or years, vulnerable to infection, and at constant risk of spreading deeper—sometimes ending in amputation.
Growth factors at 20% of normal levels = a wound that essentially gives up trying to heal.

This is where peptide therapy intervenes directly. Becaplermin (FDA-approved) supplies the missing PDGF. Other peptides address the root problems: recruiting immune cells, stimulating blood vessel formation, accelerating collagen deposition, and creating a healing-promoting microenvironment.

1997

Becaplermin (Regranex)

The FDA-Approved Foundation

Recombinant platelet-derived growth factor (PDGF) FDA-approved specifically for diabetic foot ulcers. The gold standard growth factor for wound healing.

Its role
Calling in reinforcements that your body isn't producing enough of
Typical range
0.01% topical gel application

The bottom line

Becaplermin is the only FDA-approved topical growth factor for chronic wounds. It directly signals fibroblasts and inflammatory cells to complete the healing cascade that diabetic neuropathy and vascular dysfunction have interrupted.

Each peptide targets a different aspect of the condition. Together, they create a comprehensive approach.

  1. 01Becaplermin (Regranex)The FDA-Approved FoundationCalling in reinforcements that your body isn't producing enough of
  2. 02Thymosin Beta-4The Cellular Regeneration AcceleratorEmergency repair squad sent to coordinate cell rebuilding
  3. 03BPC-157The Tissue Repair SpecialistYour gut's healing signal, applied to skin wounds
  4. 04EGF (Topical)The Skin Growth SignalTelling skin cells 'grow now' with biological authority
  5. 05GHK-CuThe Collagen RemodelerFine-tuning the collagen architecture for strength
  6. 06LL-37 (Cathelicidin)The Infection FighterAntimicrobial defense that also signals healing

5 angles of attack

  • Growth Factor Signaling

    Becaplermin (PDGF), EGF, and TB-500 provide missing growth factor signals, recruiting and activating the fibroblasts and endothelial cells needed for new tissue formation

  • Vascular Restoration

    BPC-157, TB-500, and EGF all promote angiogenesis through different mechanisms, restoring the blood flow and oxygen delivery that diabetic neuropathy and venous insufficiency have compromised

  • Collagen Architecture

    GHK-Cu builds organized collagen with proper cross-linking while other peptides recruit the cells to synthesize it, creating strong tissue rather than scar

  • Infection Prevention

    LL-37 provides antimicrobial activity and immune stimulation while other peptides restore the inflammatory balance, preventing the bacterial colonization that stalls healing

  • Comprehensive Restoration

    Together these peptides restore the complete wound healing cascade—growth signaling, vascularization, immune coordination, structural tissue formation, and epithelialization

An honest breakdown based on research and clinical reports.

Phase 1 of 5

Week 1-2

Establishing the Environment

What's happening inside

The peptides are establishing growth factor signaling. Wound bed is being cleaned and prepared. Infection risk is being managed. The basic conditions for healing are being created.

What you might notice

  • Wound stops advancing—no deeper progression
  • Infection risk decreases with LL-37 protection
  • Inflammation may shift (less localized redness, more organized response)
  • Wound bed quality improves as necrotic tissue is cleared
  • Increased granulation tissue formation visible

Watch for

If infection signs increase despite peptide therapy (increasing drainage, spreading redness, fever), may need additional antimicrobial support or systemic antibiotics. Don't assume peptides will overcome severe ongoing infection alone.

Realistic expectations

The goal here is stabilization—stopping the decline—not yet expecting active healing.

General guidelines based on research literature and clinical reports. Work with a healthcare provider experienced in peptide therapy to customize for your situation.

Important: These are general guidelines. Don't self-prescribe based on internet articles. Work with a qualified healthcare provider.

Becaplermin (Regranex) · typical range

0.01%

topical gel application

Common protocols

  • Standard: 0.01% gel applied once daily using provided measurement device (amount depends on ulcer size)
  • Typical application: 1/2 inch ribbon per square inch of ulcer surface
  • Frequency: Once daily, reassess every 1-2 weeks

Timing considerations

  • Apply after wound cleansing and debridement
  • Allow to air dry for 12 hours before covering
  • Keep wound moist between applications
  • Consistent daily application crucial for results

Cycling

Apply once daily until ulcer closes, typically 8-20 weeks

Practical tips

Injection basics

  • Subcutaneous injections into fatty tissue (abdomen, thigh, back of arm)
  • Rotate injection sites to prevent tissue irritation and lipodystrophy
  • Use insulin syringes (29-31 gauge) for comfort and precision
  • Clean injection site with alcohol swab first
  • Pinch skin, insert needle at 45-90 degree angle, inject slowly over 10 seconds
  • Do NOT inject near wound site (can cause bleeding or disturbance)

Storage

  • Reconstituted peptides require refrigeration unless otherwise specified
  • Most reconstituted peptides stable 3-4 weeks refrigerated
  • Keep away from light in dark bottles
  • Never freeze reconstituted peptides
  • Unreconstituted peptides can be stored frozen for extended periods
  • Check specific instructions for each peptide as storage varies

Reconstitution

  • Use bacteriostatic water (contains preservative), not sterile water
  • Calculate volume needed for appropriate dosing concentration
  • Inject water slowly down the side of the vial, not directly into powder
  • Swirl gently to mix - never shake vigorously
  • Wait until fully dissolved before drawing up doses
  • If reconstituted solution looks cloudy or has particles, discard and start fresh

Peptides work best as part of a comprehensive approach.

Pressure Relief

The Non-Negotiable Foundation

No peptide in the world will heal a diabetic foot ulcer if you keep walking on it. Pressure relief isn't optional—it's the baseline without which healing cannot occur.

The basics that matter

Off-loading devices
Total contact casts, removable walkers, or custom inserts that distribute pressure away from the ulcer. Non-negotiable for foot ulcers.
Proper footwear
Custom diabetic shoes with cushioning, wide toe box, and depth accommodation. Standard shoes will continue to damage healing tissue.
Activity modification
Rest periods. The wound needs metabolic resources—activity diverts them. Walking on a healing foot ulcer is like running on a broken leg.
Compression therapy (venous ulcers)
Graduated compression stockings or wraps are essential for venous ulcers. They reduce the venous pressure driving the wound.

Condition-specific tips

  • Diabetic foot ulcers: Neuropathy means you can't feel pain signals. You could be causing damage without knowing. Off-loading is preventive in ways that go beyond what you can feel.
  • Venous ulcers: Compression reduces the hydrostatic pressure that's literally forcing fluid and bacteria into the wound. It's not optional.
  • Test pressure relief effectiveness: Mark ulcer edges with a pen. If edges are shrinking weekly despite activity, pressure relief is working. If stable or growing, pressure relief is insufficient.

What to keep in mind.

  • Becaplermin is FDA-Approved But Limited

    Becaplermin (Regranex) is FDA-approved and proven for diabetic foot ulcers, but not all diabetic ulcers respond, especially if pressure relief and glucose control are inadequate. Other peptides show promise but lack FDA approval for wound healing.

  • Pressure Relief is Non-Negotiable

    No peptide will heal a chronically pressure-loaded wound. You can apply every growth factor known to medicine and still fail if pressure relief is inadequate. This is the baseline.

  • Monitor for Infection Aggressively

    Diabetic and venous ulcers are infection-prone. If signs of infection emerge (increased drainage, spreading redness, fever), additional antimicrobial treatment may be needed regardless of peptide therapy.

  • This Takes Time

    Even with optimal peptide therapy, most wounds take 8-12 weeks to close. Faster healing is possible but don't expect miracles in week 2.

This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before starting any new treatment.

PeptideWhat it doesTypical doseTiming
Becaplermin (Regranex)The FDA-Approved Foundation0.01% topical gel applicationApply after wound cleansing and debridement
Thymosin Beta-4The Cellular Regeneration Accelerator2-5 mg per weekConsistency matters more than specific time of day
BPC-157The Tissue Repair Specialist250-500 mcg per doseCan be taken at any time, though morning dosing is often preferred
EGF (Topical)The Skin Growth Signal0.01-0.05% topical formulationsMost effective in later stages of healing when wound bed is prepared
GHK-CuThe Collagen Remodeler0.5-3 mg per applicationSystemic injections best given in morning or evening consistently
LL-37 (Cathelicidin)The Infection Fighter0.1-1 mg topical or systemicEssential in early stages and if signs of infection emerge

Early wins to watch

  • Wound stops advancing
  • Infection risk decreases
  • Granulation tissue improves
  • Wound bed color improves
  • Drainage character changes
  • Epithelialization visible at margins

Support stack

  • Vitamin C (500-1000 mg daily)
  • Zinc (15-30 mg daily)
  • Arginine (3-5g daily)
  • Glutamine (5-10g daily)
  • Omega-3s (1-3g daily)
  • Protein powder (20-40g daily)
  • Vitamin A (5000-10000 IU daily)

Lifestyle priorities

  1. 1Pressure relief - absolutely critical
  2. 2Daily wound care protocol
  3. 3Glycemic control (HbA1c <7%)
  4. 4High protein nutrition
  5. 5Compression (for venous ulcers)
  6. 6Weekly wound measurement and monitoring
  7. 7Infection prevention

Chronic wounds have destroyed the quality of life for millions of people with diabetes and venous disease. Becaplermin is FDA-proven to work—and now, additional peptides offer synergistic mechanisms to accelerate healing even further. The key is aggressive pressure relief, pristine wound care, and optimized nutrition working alongside peptide therapy.

15% of diabetics develop foot ulcers. Many progress to amputation. You have evidence-based options now. Take them seriously—pressure relief especially—and track progress weekly. The outcome data shows that integrated peptide therapy + proper wound care beats standard care significantly.

0.01% topical gel applicationBecaplermin (Regranex) · typical range in this guide
Dosing calculators